The use of vaccinations for rabbits from myxomatosis and HBV

Complex vaccinations for rabbits from myxomatosis and HBV are an effective means of preserving the livestock from death.

Vaccine for rabbits from myxomatosis and HBV

Pharmacology of associated vaccination

Vaccine against myxomatosis and viral hemorrhoid associated rabbit disease is available in one of two possible strains:

• B82 rabbit myxomatous viral pathogen,
• B87 viral causative agent of rabbit hemorrhagic infection.

Outwardly, it looks like a dry porous mixture, the color of which varies from light pink to light brown.

Live vaccine for rabbits from myxomatosis and HBV is packed in sterile sealed ampoule containers with a volume of 0.5-2 ml of active substances either in glass sealed fl tips volume of 4-6 ml of the active substance.

When purchasing a dry vaccine against myxomatosis and HBV, special attention should be paid to the presence of a label with the name of the manufacturer, series and control titles, packaging date, quantitative data on the contained doses and expiration date.

The quantitative indicator of the contained immunizing doses depends on the release form in the vaccine tank for myxomatosis and viral hemorrhagic disease of rabbits and can range from 5 to 120.

Live dry vaccine can be used intramuscularly, subcutaneously or intradermally, causing sustained resistance from the third day after vaccination, actively acting throughout the calendar year.

Action Nobivak Mikso

Nobivak vaccine against myxomatosis and HBV – set from a dry lyophilized mixture of a light pink hue with the supplied solvent for the manufacture of an injection solution in a bottle. It is made from a cell line that is infected with a myxomatous viral infection with constructed rabbit GB coding genes. In addition to viral strains, the preparation includes:

• stabilizers, including 25 mg of sorbitol, 12.5 mg of gelatin hydrolyzate, 12.5 mg of casein hydrolyzate,
• sodium dihydrate – 0.065 mg.

The sterile phosphate-buffer diluent included in the vaccination kit, according to the instructions, is a mixture of sodium dihydrate (0.31 mg), potassium dihydrogen phosphate (0.21 mg) and water (1 ml) .

When dissolved, Nobivak Mixo does not precipitate or flakes, it dissolves well in a uniform transparent liquid.

Release Nobivak Mixo is organized in 1 or 50 immunizing doses in glass or plastic, packed in 5- 10 pcs.

When vaccinated with Nobivac Mikso, immunity against the effects of viral infections of myxomatosis and HBV form It is administered after a three-week period, providing the action of the active substance throughout the calendar year.

Pharmacology Lapimun Gemiks

Ukrainian vaccine against rabbit myxomatosis and HBVK Lapimun Gemiks is a medicine, including two main components:

• the inactivated pathogen source of the viral hemorrhagic infection of rabbits is presented in the form of a suspension with strain BG04, which serves as a solvent,
• myxomatous virus carrier is presented in the form of a lyophilisate strain MAV RK-1 320.

The Lapimun medication is placed in a 10 ml vial bottle, which amounts to 50 immunizing doses.

The vaccine develops stable resistance from 1-2 weeks after injection and remains active for for up to 10 months.

Resistance of rabbits to hemorrhagic infections and myxomatosis is developed no later than two weeks after vaccination with Lapimuna Gemiks.

Among the contraindications for the use of the drug in the instructions there are warnings: when using the drug for rabbits avoid vaccination one week before the birthing to avoid stress in rabbits and associated mechanical abortions.

Vaccination dosages

Depending on the type of vaccine to be vaccinated rabbits against myxomatosis and VGBK, instructions to a drug set its dosage.

Live associated vaccination

vaccine in rabbits by myxomatosis and VGBK associated applicable for prevention among healthy individuals. Moreover, in regions favorable for infections, vaccination occurs once, from a month and a half age of rabbits. In unfavorable areas where quarantine measures for myxomatosis and HBV have been imposed, rabbits are vaccinated, followed by re-vaccination of young individuals three months after the initial vaccination.

The dosage order of the drug depends on the injection method:

• for intramuscular and subcutaneous injection, the dry mixture is diluted in a proportion of 1 dosage of 0.5 ml of solution, and the prepared vaccine in volume 0.5 ml is injected in the thigh area,
• for intradermal administration of the drug 1 dose of the drug is diluted with 0.2 ml of the solution and the finished vaccine with a volume of 0.2 ml is injected into the auricle or in the area of ​​the undermine. li>

When using the associated vaccine, revaccination is recommended after 9 months.

Nobivak Mikso

Nobivak vaccines rabbits for myxomatosis and HBV. Pets by the time of the procedure should reach the age of 5 weeks, decorative dwarf breeds are also vaccinated. The vaccine from the disease must be diluted in a ratio of 1: 1, vaccinated 1 ml subcutaneously. To prevent the crawfish from getting sick, the drug should be revaccinated at least once a calendar year.

Lapimun Gemiks

Live vaccine for rabbits Lapimun gemiks in the form of a prophylactic against the disease is suitable for rabbits age category 10 weeks. It is administered once in regions with a favorable epidemiological situation from the age of 10 weeks with the existing threat of infection, followed by revaccination after reaching the age of 4 months. By the time of the first vaccination, the animal must gain a weight of at least 0.5 kg.At lower rates, the vaccine for rabbits from myxomatosis and HBV is delayed, it is done when the necessary mass is gained. For a single vaccination for rabbits from myxomatosis and HBVC, the dosage is 1.0 ml of the active substance obtained by mixing the suspension and lyophilisate.

The route of injection is subcutaneous into the area behind the shoulder blade. The Lapimun Hemix vaccine is repeated after 8 months.

When vaccination is carried out, it is necessary to follow the schedule, vaccination is carried out on time, since violation of the vaccination calendar often leads to a decrease in the effectiveness of the drug in preventing disease. Before vaccinating rabbits, for 2 weeks all animals are subject to mandatory deworming. Conducting deworming measures is also possible 2 weeks after the injection of one of the above drugs.

Side effects and special instructions

After vaccination, the animal is observed for at least 20 days.

Moreover, as possible permissible consequences can be observed:

• small enlargements of the lymph nodes that disappear after 3 days,
• some swelling at the injection site, which disappears after 1-2 week period.

There were no adverse side effects and any complications when using the vaccine against myxomatosis and HBV in rabbits. It should be borne in mind that they should not appear when the recommendations laid down in the instructions for vaccine-containing drugs are observed.

Symptomatic measures are sometimes required for those individuals who are prone to hypersensitivity.

Dry vaccine containers for rabbits for myxomatosis and HBVC with a past validity date and without labeling are not used. The same applies to color-changing mixtures, liquids with interspersed impurities, drugs that are not used after 3-4 hours after opening.

During the injection process, personal hygiene rules for working with drugs are observed.

According to general rules, the shelf life of the active drug for vaccination is 2 years, the solvent can be stored for 4 years in glass and 2 years in plastic. Medicines are stored in dry places with a temperature of 2-25 ° C, sunlight should not enter the storage rooms. Another point is to follow the instructions for the vaccine against myxomatosis and HBV in rabbits, without which it is impossible to succeed and prevent the disease. And in any case, before vaccinating the animal, you need to consult a veterinarian, or even entrust him with such an important matter.